Background illustration for clinical trials search

Paid Clinical Trials South Bend

Discover 138 paid clinical trials in South Bend, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)

for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Crown Point IN, Chicago IL, Orland Park IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06661915

Phase2, Recruiting

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Crown Point IN, Chicago IL, Evanston IL, Maywood IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06672146

Phase2, Recruiting

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

for
Advanced Hepatocellular Carcinoma,
Location: Crown Point IN, Chicago IL, Orland Park IL,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT07166406

Phase3, Recruiting

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia,
Location: Crown Point IN, Chicago IL, Evanston IL, Maywood IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554406

Phase2, Recruiting

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Crown Point IN, Chicago IL, Evanston IL, Maywood IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 59

Code: NCT05554393

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of Sigvotatug Vedotin in Advanced Solid Tumors

for
Carcinoma, Non-Small Cell Lung,
Location: Crown Point IN, Calumet City IL, Fort Wayne IN,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT04389632

Phase1, Recruiting

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

for
Acute Myeloid Leukemia
Location: Crown Point IN, Chicago IL, Evanston IL, Maywood IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06317649

Phase2, Recruiting

Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial

for
Metastatic Renal Cell Carcinoma,
Location: Crown Point IN, Chicago IL, Harvey IL, Orland Park IL,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05327686

Phase2, Recruiting

Study of Targeted Therapy vs. Chemotherapy in Patients With Thyroid Cancer

for
Refractory Differentiated Thyroid Gland Carcinoma
Location: Crown Point IN, Chicago IL, Hazel Crest IL, Oak Lawn IL,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 18+

Code: NCT06475989

Phase3, Recruiting

Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment

for
Metastatic Head and Neck Squamous Cell Carcinoma,
Location: Crown Point IN, Chicago IL, Hazel Crest IL, Oak Lawn IL,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT06589804

Phase3, Recruiting
Active & Responsive

Restorative Effects of Sleep on Everyday Health and Wellbeing: A Treatment Study

for
Chronic Insomnia
Location: Notre Dame IN
Sponsor: University of Notre Dame

Sex: All

Age: 18+

Code: NCT07156383

Recruiting

A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

for
Metabolic Dysfunction-associated Steatohepatitis
Location: South Bend IN, Dayton OH, Springboro OH, Westlake OH,
Sponsor: Eccogene

Sex: All

Age: 18 - 70+

Code: NCT07288138

Phase2, Recruiting

Chemotherapy and Internal Radiation in Treating Patients With Colorectal Cancer That Has Spread to the Liver

for
Colorectal Cancer, Metastatic Cancer
Location: Goshen IN
Sponsor: Goshen Health System

Sex: All

Age: 18+

Code: NCT00408551

Phase2, Recruiting

Study Evaluating the Benefit of Dry Needling for Patients With Neck Pain

for
Neck Pain
Location: Hobart IN
Sponsor: Integrated Therapy Practice PC

Sex: All

Age: 18 - 65

Code: NCT01301170

Recruiting

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

for
Chronic Lymphocytic Leukemia
Location: Freesoil MI, Lafayette IN, Grand Rapids MI,
Sponsor: East Valley Hematology and Oncology Medical Group

Sex: All

Age: 18+

Code: NCT00131313

Recruiting

A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Failure (CONFIRMATION-HF)

for
Heart Failure
Location: Merrillville IN, Glenview IL, Naperville IL,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06024746

Phase3, Recruiting

A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients With Heart Failure Who Are Intolerant or Not Eligible for Treatment With Steroidal Mineralocorticoid Receptor Antagonists

for
Heart Failure
Location: Merrillville IN, Milwaukee WI, Centerville OH,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06033950

Phase3, Recruiting

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

for
Heart Failure, Acute Heart Failure
Location: Merrillville IN, Chicago IL, Glenview IL, Naperville IL,
Sponsor: Colorado Prevention Center

Sex: All

Age: 18+

Code: NCT06008197

Phase3, Recruiting